Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.
      Google Scholar   
Citation:
N Engl J Med vol 394 (5) 451-62
Year:
2026
Type:
Manuscript
Funding:
AFT
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
15
Parents:
4725  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
AFT  
Corr. Author:
 
Authors:
                                                                               
Networks:
LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-OH007, LAPS-TX035, ME040   
Study
AFT-38
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: